Literature DB >> 1479322

Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis.

A Chiò1, C Magnani, E Oddenino, G Tolardo, D Schiffer.   

Abstract

STUDY
OBJECTIVE: The aim was to determine the reliability of official mortality statistics in estimating long term trends of amyotrophic lateral sclerosis (ALS) in Italy.
DESIGN: The study was a mortality follow up of cases of ALS.
SETTING: Piedmond Region, northern Italy.
SUBJECTS: Cases of ALS were identified from multiple sources between 1966 and 1985. MAIN
RESULTS: Cause of death was determined for the cases who died between 1970 and 1985. Death certificates were obtained in 488 out of 510 cases (95.7%). ALS was mentioned in 365 (74.8%) of cases. The most frequent erroneous diagnoses were multiple sclerosis and malignant tumours. Demographic variables, such as sex, age at death, province of death, and calendar year of death, did not influence the percentage of true positive cases significantly.
CONCLUSIONS: The death certificate diagnosis of ALS appears to be adequate for use in descriptive and analytical epidemiology.

Entities:  

Mesh:

Year:  1992        PMID: 1479322      PMCID: PMC1059643          DOI: 10.1136/jech.46.5.517

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  9 in total

1.  The mortality of motor neuron disease in Sweden.

Authors:  L G Gunnarsson; G Lindberg; B Söderfelt; O Axelson
Journal:  Arch Neurol       Date:  1990-01

2.  Amyotrophic lateral sclerosis in Finland. I: An epidemiologic study.

Authors:  M Jokelainen
Journal:  Acta Neurol Scand       Date:  1977-09       Impact factor: 3.209

3.  Changing mortality patterns of motor neuron disease in Japan.

Authors:  K Kondo; T Tsubaki
Journal:  J Neurol Sci       Date:  1977-07       Impact factor: 3.181

4.  The reliability of death certificate reporting for amyotrophic lateral sclerosis.

Authors:  P M Hoffman; J A Brody
Journal:  J Chronic Dis       Date:  1971-06

5.  Rising mortality from motoneuron disease in the USA, 1962-84.

Authors:  D E Lilienfeld; E Chan; J Ehland; J Godbold; P J Landrigan; G Marsh; D P Perl
Journal:  Lancet       Date:  1989-04-01       Impact factor: 79.321

6.  Motor neuron disease in the province of Turin, Italy, 1966-1980. Survival analysis in an unselected population.

Authors:  P Mortara; A Chiò; M G Rosso; M Leone; D Schiffer
Journal:  J Neurol Sci       Date:  1984 Nov-Dec       Impact factor: 3.181

7.  Increasing trend of ALS in France and elsewhere: are the changes real?

Authors:  S Durrleman; A Alperovitch
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

8.  Motor neuron disease in England and Wales, 1959-1979.

Authors:  J Buckley; C Warlow; P Smith; D Hilton-Jones; S Irvine; J R Tew
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

9.  Multiple sclerosis and motor neurone disease: survival and how certified after death.

Authors:  F O'Malley; G Dean; M Elian
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

  9 in total
  19 in total

1.  Prospective study of chemical exposures and amyotrophic lateral sclerosis.

Authors:  M G Weisskopf; N Morozova; E J O'Reilly; M L McCullough; E E Calle; M J Thun; A Ascherio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05       Impact factor: 10.154

Review 2.  Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis.

Authors:  G C Román
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

3.  Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.

Authors:  Paul H Gordon; Fanny Artaud; Albertine Aouba; Françoise Laurent; Vincent Meininger; Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2011-06-15       Impact factor: 8.082

4.  Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population.

Authors:  Marianthi-Anna Kioumourtzoglou; Ryan M Seals; Liselotte Himmerslev; Ole Gredal; Johnni Hansen; Marc G Weisskopf
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-05-06       Impact factor: 4.092

5.  Coffee, tea, and caffeine intake and amyotrophic lateral sclerosis mortality in a pooled analysis of eight prospective cohort studies.

Authors:  J Petimar; É O'Reilly; H-O Adami; P A van den Brandt; J Buring; D R English; D M Freedman; G G Giles; N Håkansson; T Kurth; S C Larsson; K Robien; L J Schouten; E Weiderpass; A Wolk; S A Smith-Warner
Journal:  Eur J Neurol       Date:  2018-11-09       Impact factor: 6.089

6.  Validating population-based registers for ALS: how accurate is death certification?

Authors:  Loraine Yeo; Catherine Lynch; Orla Hardiman
Journal:  J Neurol       Date:  2010-02-12       Impact factor: 4.849

7.  Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data.

Authors:  Raffaella Uccelli; Alessandra Binazzi; Pierluigi Altavista; Stefano Belli; Pietro Comba; Marina Mastrantonio; Nicola Vanacore
Journal:  Eur J Epidemiol       Date:  2007-09-14       Impact factor: 8.082

Review 8.  Season of birth in amyotrophic lateral sclerosis.

Authors:  V Ajdacic-Gross; J Wang; F Gutzwiller
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

9.  Familial aggregation of amyotrophic lateral sclerosis.

Authors:  Fang Fang; Freya Kamel; Paul Lichtenstein; Rino Bellocco; Pär Sparén; Dale P Sandler; Weimin Ye
Journal:  Ann Neurol       Date:  2009-07       Impact factor: 10.422

10.  Increased mortality for neurological and mental diseases following early bilateral oophorectomy.

Authors:  Cathleen M Rivera; Brandon R Grossardt; Deborah J Rhodes; Walter A Rocca
Journal:  Neuroepidemiology       Date:  2009-04-08       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.